No one ever understood why London was still “open”, with or without Advent. What was it doing? “Fully integrated” is nothing but a boiler plate paragraph. It’s meaningless without figures. Shareholders need to know whether or not Sawston will have revenues from other customers independent of any eventual DCVAX hypothetical revs?…

But you all fight me on this issue like you’re not worthy of the “Gift”. 🤷🏻‍♂️

She’s never once talked pricing or margins so the “Efficiency” angle is going to be pretty weak.

Odds at the ASM LP will explain the Plll wasn’t enough and MHRA wants a confirmatory trial which is what the 900M are for?
I’m at 75%.

Opinions; At the ASM will LP go into real detail on the Advent takeover or avoid the subject?

There’s safe and there’s manageable side effects. The later being a more likely sign the vaccine is working, IMO.

>>Is it safe?

Exactly what do you think goes on at Sawston on a daily basis? Describe 9-5 on a weekly schedule please.

With this stock there were never any real investors asking hard questions, not at the ASM and certainly not on quarterly calls. That was always a very bright red flag.

Actually we don’t. Looks more like smoke and mirrors.

>>Because we all know, that what NWBO have done in terms of science, research, results, portfolio of patents, automatic manufacturing and scaling

Can we see your letter to the company please offering them back the shares? Thanks.

Definitely not on Boxing Day. LOL

I mean…if you’re really looking for results. 🤷‍♀️

PFS using FCI (Fast Cycling Imaging) at one or two centers would produce results quickly.

😂😂🤣. 🤦‍♀️ says “A toast to GuruGary! Thank the heavens for shareholders like him.”

>>I would hope that many of our questions are answered on Monday.

Looks like stock halted so buyout maybe? 😂

LP will do anything her financiers want. Why rock the apple cart when this dilution machine runs so well? But if they do want one, a reverse spit along with a new batch of authorized is likely seen as a bridge too far to get the vote. She’ll get the 900M first then the reverse split (leaving authorized “as is”) early next year. 🤷‍♀️

GuruGary has not grown wiser, that’s for sure.

They are meek lambs.

>>You managed to list all of the excellent questions they will not answer, and I doubt the skeleton crew of investors that show up will have the balls to ask them.

Based on the replies to this it’s easy to see how the ASM will go. LOL.

1. It’s been suggested that the MAA has been sidelined by MHRA and NICE suspended. There’s nothing normal about refusing to update shareholders years after submission so why aren’t you?

2. If DCVAX-L has no serious side effects and is truly working, why hasn’t a pediatric trial begun?

3. Shareholders won’t see any ROI until you submit to the FDA so why haven’t you?

4. Why do you refuse to tell investors Advent’s revenue figures?

5. Why is your public facing website so awful and out of date given you rely so heavily on retail investors?

6. Why do you continue to refuse to hold quarterly calls?

7. Why are shareholders forced to deal with terrible dilutive financing when you’ve built two successful CDMO’s?

You should’ve dated these transcripts. Since T cell therapy has shown improvement in GBM. And with the confusion on pseudo progression we don’t know how many non progression patients actually moved into the L arm, and why the control depleted?

This one always bother me. I agree, it is surprising…and worrisome, imo.

>>Dr. Liau: Surprisingly, no. We actually—there was actually very good tolerability for the vaccine and the safety profile was exceptionally benign.

https://lab.moffitt.org/czerniecki/research/

Excuses excuses excuses.

Of course.

>>Is it possible that he can blow smoke up investor's @$$e$ and claim plausible deniability because he isn't an employee?

All the nifty graphics in the world won’t change things. Ask her why she doesn’t do road shows or make any open market purchases?

LOL. You’re not going to catch her with those. I’d start with the following:

1. It’s been suggested that the MAA has been sidelined by MHRA and NICE suspended. There’s nothing normal about refusing to update shareholders years after submission so why aren’t you?

2. If DCVAX-L has no serious side effects and is truly working, why hasn’t a pediatric trial begun?

3. Shareholders won’t see any ROI until you submit to the FDA so why haven’t you?

4. Why do you refuse to tell investors Advent’s revenue figures?

5. Why is your public facing website so awful and out of date given you rely so heavily on retail investors?

6. Why do you continue to refuse to hold quarterly calls?

7. Why are shareholders forced to deal with terrible dilutive financing when you’ve built two successful CDMO’s?

“Many trials in the past 25 years have looked at changing the trajectory of glioblastoma,” Dr. Connelly said. “There have been small successes, but none has made a significant impact. The Diet2Treat trial may enable patients to take control and modify their lifestyle in a way that could influence the outcome of their disease.”

https://www.froedtert.com/stories/ketogenic-diet-influence-glioblastoma

I was thinking more in terms of Proof of life.

Scott couldn’t even be bothered to comment on the takeover press release so I wouldn’t put much faith in his hanging round. Do you think he’ll be at the ASM?

Everyone wants to see what LP looks like.

What a dopey response for an alleged shareholder. Take note, people.

Will they allow a video recording?

First was Flip and now it looks like another AI breakup is inevitable. 😂

Amazing that Advent would post job openings while having an outdated website that doesn’t even mention they’re now an American publicly traded company, and with no news posted since 2024. I wouldn’t go to work for them.🤷‍♀️

Oh yeah, that little thing.🤷‍♀️ Not even to mention Liau was a no-show. And the doc who did present that day turns out to have his own GBM therapy.🤷🏻‍♂️

>>Perhaps the disclosure at NYAS that the randomized trial failed to establish either a PFS or OS benefit for those randomized to DCvax-L?

Despicable.

OK, here we go; Oooone laaaast tiiiiime!!!…for 2025:

IS IT FRIDAY YET?

Nope, not there. But fun reading. Maybe next time.🤷‍♀️

https://archive.is/dGjw0

Just keep the one trial running forever like it says on their website, and global approval is a certainty.

Well, that’s true. These disciples are timid as sheep so rarely does anything of importance ever get asked, and certainly not answered in these ASM encounters. It might be smarter to have Bigger ask retail’s questions, but I doubt he’ll even be on the call?

There’s zero harm in asking the question just so it’s on the record. At this point there may be no one going in person so it won’t matter what questions are asked since she’ll pick maybe three (scrappy audio only) and quickly close the meeting. Bet she’s praying for a snow storm.

Flipper says 🤷🏻‍♂️